Evidence Summary
- Evidence Level
- Preliminary
- Mechanism
- Enrollment: Actual, Sponsor Type: Other, Unknown / General
- Safety
- Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
- Dosing
- See linked studies/trials for reported doses and durations; typical protocols vary widely.
Acetylcholinesterase inhibitor. RCT support for hemodynamics in POTS. 30-60mg TID. Cholinergic SE dose-limiting. Targeted for hyperadrenergic POTS.
Clinical Trials
1 trial(s) registered
| NCT ID | Title | Phase | Status |
|---|---|---|---|
| NCT03674541 | The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome | Phase 2 | Completed |
Key Studies / References
- See linked studies